Medical expert of the article
New publications
Treatment and prevention of tetanus
Last reviewed: 04.07.2025

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Treatment of tetanus should be accompanied by a therapeutic and protective regimen that helps reduce the frequency of seizures. Patients are placed in separate wards, maximally isolating them from external irritants that can provoke seizures.
Of great importance is full-fledged enteral (tube) and/or parenteral nutrition with special nutritional mixtures: Nutriprobe, Isocal HCN, Osmolite HN, Pulmocare, concentrated glucose solutions (10-70%), amino acid mixtures and fat emulsions. Nutrition is carried out at the rate (taking into account the high energy expenditure during convulsions and high temperature) of 2500-3000 kcal/day.
Etiotropic treatment of tetanus is very limited. Surgical treatment of wounds is performed to remove non-viable tissues, foreign bodies, open pockets, create an outflow of wound discharge, which prevents further production of toxin by the pathogen. Before treatment, the wound is injected with anti-tetanus serum in a dose of 1000-3000 IU. Surgical manipulations are performed under general anesthesia to avoid seizures.
To neutralize the circulating exotoxin, 50-100 thousand IU of purified concentrated anti-tetanus serum or, which is preferable, 900 IU of anti-tetanus immunoglobulin are administered intramuscularly once. The toxin fixed in the tissues cannot be affected by any means. According to a number of authors, neither early nor repeated administration of these drugs prevents the development of severe forms and fatal outcomes of the disease. Therefore, pathogenetic methods of therapy play an important role.
In moderate and severe cases of tetanus, muscle relaxants must be prescribed, so patients are immediately transferred to artificial ventilation. It is preferable to use long-acting antidepolarizing muscle relaxants: tubocurarine chloride 15-30 mg/h, alcuronium chloride 0.3 mg/(kg-h), pipecuronium bromide 0.04-0.06 mg/(kg-h), atracuronium besylate 0.4-0.6 mg/(kg-h). Since artificial ventilation is carried out in a prolonged mode (up to 3 weeks), it is advisable to use tracheostomy and modern respiratory equipment with high-frequency ventilation systems and positive expiratory pressure.
In addition, it is necessary to use anticonvulsant treatment for tetanus. In mild and moderate forms of the disease, patients are given neuroleptics (chlorpromazine up to 100 mg/day, droperidol up to 10 mg/day), tranquilizers (diazepam up to 40-50 mg/day), chloral hydrate (up to 6 g/day in enemas) parenterally. They are used both alone and in combination with narcotic analgesics (neuroleptanalgesia), antihistamines (diphenhydramine 30-60 mg/day, promethazine and chlorpyramine 75-150 mg/day), barbiturates (sodium thiopental and hexobarbital up to 2 g/day). The specified daily doses of the drugs are administered intramuscularly or intravenously in 3-4 doses. Combined administration of drugs potentiates their effect. It is recommended to take beta-blockers (propranolol, bisoprolol, atenolol), which reduce the influence of the sympathetic nervous system. When using muscle relaxants, it is necessary to use anti-bedsore mattresses and perform regular chest massage to reduce the likelihood of pneumonia.
Antibiotics should be prescribed to patients with severe forms of tetanus for the prevention and treatment of pneumonia and sepsis. Preference is given to semisynthetic penicillins (ampicillin + oxacillin 4 g/day, carbenicillin 4 g/day), second- and third-generation cephalasporins (cefotaxime, ceftriaxone at a dose of 2-4 g/day, cefuroxime 3 g/day), fluoroquinolones (ciprofloxacin, levofloxacin 0.4 g/day) and other broad-spectrum antibiotics.
In severe cases of the disease, infusion therapy for tetanus (crystalloids) is indicated to combat hypovolemia under the control of hematocrit, hemodynamic parameters such as central venous pressure, pulmonary capillary wedge pressure, cardiac output, and total peripheral vascular resistance. It is indicated to prescribe agents that improve microcirculation (pentoxifylline, nicotinic acid) and reduce metabolic acidosis (sodium bicarbonate solution in calculated doses). The use of hyperbaric oxygenation, immunoglobulins - normal human immunoglobulin (pentaglobin) and metabolic agents (large doses of water-soluble vitamins, trimetazidine, meldonium, anabolic steroids) is effective. In the case of prolonged mechanical ventilation, patient care issues come to the fore.
Approximate periods of incapacity for work
Determined individually.
Clinical examination
Not regulated.
[ 5 ], [ 6 ], [ 7 ], [ 8 ], [ 9 ], [ 10 ], [ 11 ], [ 12 ]
How to prevent tetanus?
Specific prophylaxis of tetanus
The vaccination calendar provides for three vaccinations of children with an interval of 5 years, the tetanus vaccine is used. In developing countries, vaccination of women of childbearing age is important for the prevention of neonatal tetanus. Tetanus toxoid or the associated DPT vaccine is used. Since the degree of immunity is unknown in each specific case and some part of the population is not vaccinated, emergency prevention is necessary if there is a risk of developing the disease. For this purpose, careful primary and surgical treatment of wounds is carried out, in case of injuries with damage to the integrity of the skin and mucous membranes, burns and frostbite of the second and third degrees, animal bites, out-of-hospital births and abortions, heterogeneous antitetanus serum is administered at a dose of 3000 IU or highly active human antitetanus immunoglobulin at a dose of 300 IU. Passive immunization does not always prevent the disease, which is why active immunization with tetanus toxoid in a dose of 10-20 ME is necessary. Serum and toxoid should be administered to different parts of the body.
Non-specific prophylaxis of tetanus
Injury prevention is of great importance.
What is the prognosis for tetanus?
Tetanus always has a serious prognosis. Timely treatment of tetanus and its quality also affects the prognosis of this disease. Without treatment, the mortality rate reaches 70-90%, but even with adequate and timely intensive care it is 10-20%, and in newborns - 30-50%. In convalescents, long-term asthenia is observed, in uncomplicated cases, complete physical recovery occurs. Fractures and severe deformations of the spine can lead to disability.